Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles.
about
The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migrationKnock-down of PRAME increases retinoic acid signaling and cytotoxic drug sensitivity of Hodgkin lymphoma cellsCharacterization of Alstrom Syndrome 1 (ALMS1) Transcript Variants in Hodgkin Lymphoma Cells.Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed-Sternberg cells.Bystander cells and prognosis in Hodgkin lymphoma. Review based on a doctoral thesis.The histone variant H2A.Bbd is enriched at sites of DNA synthesis.Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies.Expression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) in tumor cellsSinus-lining cells of the lymph nodes recognized as a dendritic cell type by the new monoclonal antibody Ki-M9.Lack of effect of colony-stimulating factors, interleukins, interferons, and tumor necrosis factor on the growth and differentiation of cultured Reed-Sternberg cells. Comparison with effects of phorbol ester and retinoic acidLymphocyte functional antigens stabilize agglutination between Reed-Sternberg cells and T cells, but are not responsible for homotypic binding of Hodgkin's Reed-Sternberg cellsCultured Reed-Sternberg cells HDLM-1 and KM-H2 can be induced to become histiocytelike cells. H-RS cells are not derived from lymphocytes.Expression of p55 (Tac) interleukin-2 receptor (IL-2R), but not p75 IL-2R, in cultured H-RS cells and H-RS cells in tissues.Aberrant expression of T cell and B cell markers in myelocyte/monocyte/histiocyte-derived lymphoma and leukemia cells. Is the infrequent expression of T/B cell markers sufficient to establish a lymphoid origin for Hodgkin's Reed-Sternberg cells?Production of tumor necrosis factor-alpha and lymphotoxin by cells of Hodgkin's neoplastic cell lines HDLM-1 and KM-H2Heterogeneity of interleukin 1 production in cultured Reed-Sternberg cell lines HDLM-1, HDLM-1d, and KM-H2.Expression of prostaglandin H synthase (cyclooxygenase) in Hodgkin's mononuclear and Reed-Sternberg cells. Functional resemblance between H-RS cells and histiocytes or interdigitating reticulum cells.Correlation of c-fos/c-jun expression with histiocytic differentiation in Hodgkin's Reed-Sternberg cells. Examination in HDLM-1 subclones with spontaneous differentiation.Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's diseaseMutation of p53 in primary biopsy material and cell lines from Hodgkin disease.CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells.Stimulation of the hypoxia pathway modulates chemotherapy resistance in Hodgkin's lymphoma cells.Surfaceome of classical Hodgkin and non-Hodgkin lymphoma.Differences in nuclear DNA organization between lymphocytes, Hodgkin and Reed-Sternberg cells revealed by structured illumination microscopy.BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts.Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts.Hodgkin's lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responses.Expression and Regulation of the Endogenous Retrovirus 3 in Hodgkin's Lymphoma Cells.Expression of mast cell tryptases in Hodgkin and Reed-Sternberg (HRS) cells.The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma.CD30 cell graphs of Hodgkin lymphoma are not scale-free--an image analysis approach.Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines.A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells.The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.History and classification of human leukemia-lymphoma cell lines.In vitro culture studies of childhood myelodysplastic syndrome: establishment of the cell line MUTZ-1.Lineage-Specific Monocytic Esterase, a Distinct Marker for Leukemias of Monocytic Origin: Cytochemical, Isoenzymatic and Biochemical Features.Extracellular matrix does not induce the proliferation, but promotes the differentiation, of Hodgkin's cell line HDLM-1.
P2860
Q21146664-B8877301-2E71-48DE-8607-C522057AE6D3Q28486108-1A577E11-84C3-41E0-85DB-13001AA07CA9Q30313499-B5461E7B-255F-4DE4-974E-5774C78636DFQ30560427-7A1055B0-6BF1-485C-9F94-29D5D8B7898AQ33208378-66BE8157-E669-426C-9DBB-80C632EDDE17Q33698689-30CC2C57-BA11-4357-B035-DA9DAB4627D9Q33713735-8875F371-4776-41D8-B2ED-365D6A942E04Q35126260-18D3DC29-C4CA-4663-9DE9-93F631E37733Q35763806-92156295-8CAE-4446-B4DB-6A248C064AF3Q35811315-69510E6B-E17B-4FE9-9725-A9E6E4E9E0D6Q35811548-FD2F9928-7084-437A-B02E-0CCF0B8F3B93Q35811817-D7D15042-C327-4361-B640-DC3B80AC7C41Q35811874-2C12DE41-4A25-4D72-9D3A-C17DCFF4D5E4Q35816024-E427C961-77B5-4A60-96B6-AA86D8E09ABEQ35817197-F64F01CB-E826-48A0-9971-E0789309F266Q35817633-B2CB9734-DF0C-4808-AA2E-B6882CCF4972Q35818633-68F06E7F-044E-45FF-A6A7-ABF89F13A4B5Q35830942-758106D4-C0BB-4F19-927C-32C5D7AC4CEDQ35831873-DDFB77A3-DDCE-411A-9FB2-79A3A9D1CEB8Q36201737-74B554BC-AB71-4989-BDD3-1EA61387D9E7Q36288217-2B94D3F9-0144-4AB5-AF99-444501AD3CDAQ38320268-8E1DD674-549C-4F02-9493-0D75E4590C06Q38807893-0DCC1B91-1EF2-417C-A2A8-927D657542B4Q38863923-96DC18E8-6D92-4C13-BEA1-F4F0E063310EQ39018946-485FD1B6-BB9C-4867-AD6E-AA08A9A67166Q39021652-8C6A7C7F-9E10-4A87-9D2D-06092D55C1E7Q39202496-F8B2F083-5742-4C4A-A59D-274A10D65A0AQ39379516-92D5B098-71F7-4DF8-A93F-2E82BFB65A5DQ39386056-F89F1D3E-C3F2-4C10-A60B-725EF632D52FQ40049855-FC4ED753-E776-42E1-9096-5504C1B77206Q40220487-828C121B-16C4-414A-8883-90E4EFB05B5AQ40312648-71B737EE-C612-4BE3-908F-0F4C60C09B5AQ40486400-B7483340-076F-4746-876D-45F251EC33C2Q40605843-A57353A6-A74E-4E1E-B0BD-8D758CCC0C24Q40770329-D8AF9819-31B3-42FF-8415-2BB1B8173A0CQ40781126-A3EFEE84-3FA2-4E07-9524-B743F8D0B13EQ40985478-6D7E7244-95B0-4782-9AA5-3DFA8CA37141Q41117851-B13B92C7-DA74-40AC-8678-49843AE9FE81Q41162067-172F4C17-E24C-442B-A277-19631C694F88Q42045311-C8B9B97F-2FC4-49D9-B0C5-85D7F9FE194C
P2860
Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Hodgkin's disease derived cell ...... ogical and isoenzyme profiles.
@en
Hodgkin's disease derived cell ...... ogical and isoenzyme profiles.
@nl
type
label
Hodgkin's disease derived cell ...... ogical and isoenzyme profiles.
@en
Hodgkin's disease derived cell ...... ogical and isoenzyme profiles.
@nl
prefLabel
Hodgkin's disease derived cell ...... ogical and isoenzyme profiles.
@en
Hodgkin's disease derived cell ...... ogical and isoenzyme profiles.
@nl
P2093
P4510
P1433
P1476
Hodgkin's disease derived cell ...... ogical and isoenzyme profiles.
@en
P2093
P304
P356
10.1016/0145-2126(86)90084-6
P577
1986-01-01T00:00:00Z